Sally Adams
Direttore/Membro del Consiglio presso Scancell Ltd.
Patrimonio netto: 11 070 $ in data 30/06/2024
Profilo
Sally Elizabeth Adams is currently a Director & Development Director at Scancell Ltd.
She previously worked as an Executive Director & Chief Development Officer at Scancell Holdings Plc, a Development Director at Neures Ltd., and Head-Neurology & Virology at Ligand UK Ltd.
Adams holds a doctorate from Imperial College London and a graduate degree from the University of Cambridge.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SCANCELL HOLDINGS PLC
0.01% | 19/12/2023 | 78 714 ( 0.01% ) | 11 070 $ | 30/06/2024 |
Posizioni attive di Sally Adams
| Società | Posizione | Inizio |
|---|---|---|
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sally Adams
| Società | Posizione | Fine |
|---|---|---|
| SCANCELL HOLDINGS PLC | Direttore/Membro del Consiglio | 05/02/2024 |
| VERNALIS | Corporate Officer/Principal | - |
| Neures Ltd. | Corporate Officer/Principal | - |
Formazione di Sally Adams
| Imperial College London | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCANCELL HOLDINGS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
| Neures Ltd. |
- Borsa valori
- Insiders
- Sally Adams
